Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▾	Revenue growth	Diluted EPS
OTLC	Oncotelic Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$249.28M	n/a	94.9%	n/a	$0.59
RIGL	Rigel Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	$367.02M	n/a	93.8%	n/a	$19.48
ZTS	Zoetis Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.47B	$2.67B	28.2%	80.2%	2.3%	$6.02
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
QTTB	Q32 Bio Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.74M	$29.82M	55.5%	71.0%	n/a	$2.42
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
PTPI	Petros Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.91M	n/a	66.7%	n/a	-$1.56
ENLV	Enlivex Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.24B	n/a	63.9%	n/a	$25.48
ZVRA	Zevra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$106.47M	$83.23M	78.2%	53.8%	350.9%	$1.35
PTIX	Protagenic Therapeutics, Inc.\new Manufacturing · Year ended 2026-03-31 · USD	n/a	$1.37M	n/a	52.2%	n/a	$0.59
ETST	Earth Science Tech, Inc. Manufacturing · Year ended 2026-03-31 · USD	$35.70M	$3.63M	10.2%	51.8%	7.8%	$0.012
AUPH	Aurinia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$287.20M	n/a	49.4%	n/a	$2.07
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03
ABEO	Abeona Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$71.18M	n/a	44.7%	n/a	$1.01
EOCN	Galmed Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$6.90M	n/a	43.7%	n/a	$2.39
CRMD	CorMedix Inc. Manufacturing · Year ended 2025-12-31 · USD	$311.71M	$163.06M	52.3%	40.2%	617.0%	$2.04
ALNY	Alnylam Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.71B	$313.75M	8.4%	39.8%	65.2%	$2.33
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
HCM	HUTCHMED (China) Ltd Manufacturing · Year ended 2025-12-31 · USD	$548.51M	$456.91M	83.3%	36.5%	-13.0%	$0.52
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
MRK	Merck & Co., Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.01B	$18.25B	28.1%	34.7%	1.3%	$7.28
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
ORMP	Oramed Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$64.05M	n/a	32.1%	n/a	$1.50
ACAD	Acadia Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$1.07B	$391.00M	36.5%	31.9%	11.9%	$2.30
BHC	Bausch Health Companies Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.27B	$120.00M	1.2%	31.8%	6.7%	$0.42

Rows per page: 2550 100